£213.13

Springer Cancer Neutron Capture Therapy

Price data last checked 98 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£213 today · previous high £213 · all-time low £185

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 633 days • 633 data points (No recent data available)

Historical
Generating forecast...
£213.13 £182.25 £188.99 £195.73 £202.46 £209.20 £215.94 23 May 2024 28 October 2024 04 April 2025 09 September 2025 14 February 2026

Price Distribution

Price distribution over 633 days • 7 price levels

Days at Price
Current Price
15 days 16 days 192 days 346 days 2 days 3 days 59 days · current 0 87 173 260 346 £185 £187 £202 £203 £204 £207 £213 Days at Price

Price Analysis

Most common price: £203 (346 days, 54.7%)

Price range: £185 - £213

Price levels: 7 different prices over 633 days

Description

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
17 May 2013
Listed Since
06 August 2014

Barcode

No barcode data available

Similar Products You Might Like

Advances in Boron Neutron Capture Therapy (Non-serial Publications)
96% match

Advances in Boron Neutron Capture Therapy (Non-serial Publications)

£53.96 28 Feb 2026
Springer - Advances in Neutron Capture Therapy Book
96% match

Springer - Advances in Neutron Capture Therapy Book

Springer

£142.76 26 Feb 2026
Advances in Neutron Capture Therapy: 5th International Symposium
96% match

Advances in Neutron Capture Therapy: 5th International Symposium

Springer

£167.39 12 Dec 2025
Springer - Neutron Capture Therapy: Principles and Applications
95% match

Springer - Neutron Capture Therapy: Principles and Applications

Springer

£104.29 20 Feb 2026
Progress in Neutron Capture Therapy for Cancer: International Symposium Proceedings
95% match

Progress in Neutron Capture Therapy for Cancer: International Symposium Proceedings

Springer

£80.56 08 Mar 2026
Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)
94% match

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Springer

£75.01 10 Mar 2026
Neuro-Oncology: Advances in Diagnosis, Treatment, and Research
94% match

Neuro-Oncology: Advances in Diagnosis, Treatment, and Research

£44.99 07 Mar 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
94% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£151.95 18 Feb 2026
Robotergeführte Radiochirurgie: Extracranielle Indikationen
94% match

Robotergeführte Radiochirurgie: Extracranielle Indikationen

De Gruyter

£81.16 18 Apr 2026
Weichteilsarkome: Diagnostik und aktuelle Therapiestrategien
94% match

Weichteilsarkome: Diagnostik und aktuelle Therapiestrategien

Springer

£46.99 01 Apr 2026
Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)
94% match

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Springer

£165.83 12 Apr 2026
Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions
94% match

Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions

Academic Press

£98.89 11 Mar 2026
New Approaches in the Treatment of Cancer (Cancer Etiology, Diagnosis and Treatments)
94% match

New Approaches in the Treatment of Cancer (Cancer Etiology, Diagnosis and Treatments)

£75.99 06 Mar 2026
Tumors of the Pediatric Central Nervous System
94% match

Tumors of the Pediatric Central Nervous System

Thieme

£182.40 11 Apr 2026
Polymeric Gene Delivery Systems (Topics in Current Chemistry Collections)
94% match

Polymeric Gene Delivery Systems (Topics in Current Chemistry Collections)

Springer

£165.31 11 Jan 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6
94% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6

Springer

£165.82 14 Jan 2026
Evidence based practice in Neuro-oncology
94% match

Evidence based practice in Neuro-oncology

Springer

£81.90 27 Feb 2026
Nanooncology: Engineering nanomaterials for cancer therapy and diagnosis (Nanomedicine and Nanotoxicology)
94% match

Nanooncology: Engineering nanomaterials for cancer therapy and diagnosis (Nanomedicine and Nanotoxicology)

Springer

£118.99 13 Apr 2026
The Physics of Modern Brachytherapy for Oncology (Series in Medical Physics and Biomedical Engineering)
94% match

The Physics of Modern Brachytherapy for Oncology (Series in Medical Physics and Biomedical Engineering)

CRC Press

£151.07 13 Dec 2025
UICC Manual of Clinical Oncology
94% match

UICC Manual of Clinical Oncology

Wiley

£119.69 06 Feb 2026
Neuro-Oncology Compendium for the Boards and Clinical Practice
94% match

Neuro-Oncology Compendium for the Boards and Clinical Practice

£85.00 09 Jan 2026
14 MeV Neutrons: Physics and Applications
94% match

14 MeV Neutrons: Physics and Applications

CRC Press

£48.27 28 Feb 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
94% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£174.97 28 Mar 2026
Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)
94% match

Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)

Springer

£103.65 10 Apr 2026